NEW YORK, July 18, 2018 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of
Rosetta Genomics Ltd. Rosetta Genomics Ltd.’s stock was suspended on May 22, 2018 and has not traded on Nasdaq since that
time.
Nasdaq also announced that it will delist the warrant of ConvergeOne Holdings, Inc. ConvergeOne Holdings,
Inc.’s warrant was suspended on June 28, 2018 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of FC Global Realty Incorporated. FC Global
Realty Incorporated’s stock was suspended on June 20, 2018 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of Concordia International Corp. Concordia
International Corp.’s stock was suspended on June 08, 2018 and has not traded on Nasdaq since that time.
Finally, Nasdaq announced that it will delist the common stock of Argos Therapeutics, Inc. Argos
Therapeutics, Inc.’s stock was suspended on April 25, 2018 and has not traded on Nasdaq since that time.
Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting for each of
these companies. The delistings become effective ten days after the Form 25 is filed. For news and additional
information about the companies, including the basis for the delistings and whether the companies’ securities are trading on
another venue, please review the companies’ public filings or contact the company directly.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the
Nasdaq Rule 5800 Series, available on the Nasdaq Web site: http://www.cchwallstreet.com/NasdaqTools/bookmark.asp?id=nasdaq-rule_5800&manual=/nasdaq/main/nasdaq-equityrules/.
NDAQO
